Immunology of Celiac Disease by Focused on Vaccine Therapy

Mohammad Rostami Nejad^1,

¹Celiac disease department, Gastroenterology and Liver diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Cite this paper:
Mohammad Rostami Nejad. Immunology of Celiac Disease by Focused on Vaccine Therapy. International Journal of Celiac Disease. 2015; 3(4):115-117. doi: 10.12691/ijcd-3-4-4

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Rostami-Nejad M, Romanos J, Rostami K, Ganji A, Ehsani-Ardakani MJ, Bakhshipour AR, Zojaji H, Mohebbi SR, Zali MR, Wijmenga C. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patients. World J Gastroenterol 2014; 20: 6302-6308.
[2]	Mansueto P, Seidita A, Alcamo A, Carroccio A. Non-Celiac Gluten Sensitivity: Literature Review. J Am Coll Nutr 2014; 33:39-54.
[3]	Monteleone I, Sarra M, DelVecchio Blanco G, Paoluzi OA, Franz`e E, Fina D. Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010; 184: 2211-2218.
[4]	Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med 2011;9: 23.
[5]	Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Carten`ı M, Casolaro V, Fasano A: Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010; 152: 75-80.
[6]	Volta U, Tovoli F, Cicola R, Parisi C, FabbriA, Piscaglia M, Fiorini E, Caio G: Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012;46:680-685.
[7]	Le´on F, S´anchez L, Camarero C, Roy G: Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease. Dig Dis Sci 2005.50:593-600.
[8]	Fern´andez S,Molina IJ, Romero P, Gonz´alez R, Pe˜na J, S´anchez F, etal. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol 2011;106:528-538.
[9]	Fina D, Sarra M, Caruso R, Del Vecchio Blanco G, Pallone F, MacDonald TT, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 2008; 57: 887-892.
[10]	Eir´o N, Gonz´alez-Reyes S, Gonz´alez L, Gonz´alez LO, Altadill A, Andicoechea A, et al. Duodenal expression of toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci 2012;57:2278-2285.
[11]	Szebeni B, Veres G, Dezsofi A, Rusai K, Vannay A, Bokodi G, et al. Increased mucosal expression of toll-like receptor (TLR)2 and TLR4 in coeliac disease. J Pediatr Gastroenterol Nutr 2007;45: 187-193.
[12]	Kalliom¨aki M, Satokari R, L¨ahteenojaH, V¨ah¨amiko S, Gr¨onlund J, Routi T, et al. Expression of microbiota, toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J Pediatr Gastroenterol Nutr 2012; 54:727-732.
[13]	Camilleri M, Madsen K, Spiller R, Van Meerveld BG, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012; 24:503-512.
[14]	Bertolazzi S, Lanzarotto F, Zanini B, Ricci C, Villanacci V, Lanzini A. Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet. BMC Gastroenterol 2011;11:119.
[15]	Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009;1165:195-205.
[16]	Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 2006;41:408-419.
[17]	Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005; 579: 4851-4855.
[18]	Ciccocioppo R, Finamore A, Ara C, Di Sabatino A, Mengheri E, Corazza GR. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 2006;125:502-511.
[19]	Salvati VM, Mazzarella G, Gianfrani C, Levings MK, Stefanile R, De Giulio B, et al. Recombinant human interleukin suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 2005; 54: 46-53.
[20]	Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med 2010; 2: 41-51.
[21]	Stein J, Schuppan D. Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy. Viszeralmedizin. 2014;30:156-165.
[22]	Riedmann EM. Human vaccines: news. Hum Vaccin Immunother. 2012; 8:1550-1553.
[23]	Crespo Pérez L, Castillejo de Villasante G, Cano Ruiz A, León F. Non-dietary therapeutic clinical trials in coeliac disease. Eur J Inter Med. 2012; 23: 9-14.